Showing results 1 to 20 of 274
next >
| Issue Date | Title | Author(s) |
| 2015 | Adapting the CHEERS statement for reporting cost-benefit analysis. | Sanghera, S; Frew, E; Roberts, T |
| 2014 | Addressing liver disease in the UK: A blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis | Williams, R; Aspinall, R; Bellis, M; Camps-Walsh, G; Cramp, M; Dhawan, A; Ferguson, J; Forton, D; Foster, G; Gilmore, SI; Hickman, M; Hudson, M; Kelly, D; Langford, A; Lombard, M; Longworth, L; Martin, N; Moriarty, K; Newsome, P; O'Grady, J; Pryke, R; Rutter, H; Ryder, S; Sheron, N; Smith, T |
| 2013 | Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF project I-A: Study protocol for a randomized controlled trial | O'Meara, E; Mielniczuk, LM; Wells, GA; deKemp, RA; Klein, R; Coyle, D; Mc Ardle, B; Paterson, I; White, JA; Arnold, M; Friedrich, MG; Larose, E; Dick, A; Chow, B; Dennie, C; Haddad, H; Ruddy, T; Ukkonen, H; Wisenberg, G; Cantin, B; Pibarot, P; Freeman, M; Turcotte, E; Connelly, K; Clarke, J; Williams, K; Racine, N; Garrard, L; Tardif, J-C; DaSilva, J; Knuuti, J; Beanlands, R |
| 2008 | Analysis of consultants' NHS and private incomes in England in 2003/4 | Morris, S; Elliott, B; Ma, A; McConnachie, A; Rice, N; Skåtun, D; Sutton, M |
| 2014 | Application of a policy framework for the public funding of drugs for rare diseases | Winquist, E; Coyle, D; Clarke, JTR; Evans, GA; Seager, C; Chan, W; Martin, J |
| 2012 | Applying economic evaluation to public health interventions: The case of interventions to promote physical activity | Trueman, P; Anokye, NK |
| 2009 | ARTISTIC: A randomised trial of human papillomavirus (HPV) testing in primary cervical screening | Kitchener, HC; Almonte, M; Gilham, C; Dowie, R; Stoykova, B; Sargent, A; Roberts, C; Desai, M; Peto, J |
| 2009 | Assessing the impact of England's National Health Service R&D Health Technology Assessment program using the "payback" approach | Raftery, J; Hanney, S; Green, C; Buxton, MJ |
| 2008 | Assessing the impact of health technology assessment in the Netherlands | Oortwijn, WJ; Hanney, S; Ligtvoet, A; Hoorens, S; Wooding, S; Grant, J; Buxton, MJ; Bouter, LM |
| 2010 | Assessing the payback from health R & D: From ad hoc studies to regular monitoring | Buxton, MJ; Croxson, B; Hanney, S |
| 2013 | An assessment of opportunities and challenges for public sector involvement in the maternal health voucher program in Uganda | Kanya, L; Okal, J; Obare, F; Njuki, R; Abuya, T; Bange, T; Warren, C; Askew, I; Bellows, B |
| 2013 | An assessment of validity and responsiveness of generic measures of health-related quality of life in hearing impairment | Yang, Y; Longworth, L; Brazier, J |
| 2008 | The Australian Research Quality Framework: A live experiment in capturing the social, economic, environmental, and cultural returns of publicly funded research | Donovan, C |
| 2014 | A bayesian meta-analysis of multiple treatment comparisons of systemic regimens for advanced pancreatic cancer | Chan, K; Shah, K; Lien, K; Coyle, D; Lam, H; Ko, Y-J |
| 2012 | Bayesian meta-analysis on medical devices: Application to implantable cardioverter defibrillators | Youn, J-H; Lord, J; Hemming, K; Girling, A; Buxton, M |
| 2015 | Benefits from clinicians and healthcare organisations engaging in research | Hanney, S; Soper, B; Jones, TH; Boaz, A |
| 2009 | Benefits of global partnerships to facilitate access to medicines in developing countries: A multi-country analysis of patients and patient outcomes in GIPAP | Kanavos, P; Vandoros, S; Garcia-Gonzalez, P |
| 2013 | Beyond the 'postmodern university' | Donovan, C |
| 2013 | Binary choice health state valuation and mode of administration: Head-to-head comparison of online and CAPI | Longworth, L; Brazier, J; Rowen, D; Bansback, N; Devlin, N; Tsuchiya, A |
| 2013 | Breast cancer in lesbians and bisexual women: Systematic review of incidence, prevalence and risk studies | Meads, C; Moore, D |
